Search Results - Ugrenovic-Petrovic, Milijana

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A Phase I/IB Trial of Binimetinib in Combination with Erlotinib in NSCLC Harboring Activating KRAS or EGFR Mutations

    A Phase I/IB Trial of Binimetinib in Combination with Erlotinib in NSCLC Harboring Activating KRAS or EGFR Mutations by Saltos, Andreas N., Creelan, Ben C., Tanvetyanon, Tawee, Chiappori, Alberto A., Antonia, Scott J., Shafique, Michael R., Ugrenovic-Petrovic, Milijana, Sansil, Samer, Neuger, Anthony, Ozakinci, Hilal, Boyle, Theresa, Kim, Jongphil, Haura, Eric B., Gray, Jhanelle E.

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    Abstract CT515: A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring KRAS or EGFR mutation

    Abstract CT515: A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring KRAS or EGFR mutation by Saltos, Andreas N., Creelan, Benjamin C., Tanvetyanon, Tawee, Chiappori, Alberto A., Antonia, Scott J., Shafique, Michael R., Ugrenovic-Petrovic, Milijana, Sansil, Samer, Neuger, Anthony M., Kim, Jongphil, Haura, Eric, Gray, Jhanelle

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: